Results 171 to 180 of about 65,545 (257)

Renal Function and 4‐Year Outcomes in Edoxaban‐Treated Patients: A Sub‐Analysis From the ETNA‐AF Europe Study

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 11, November 2026.
The ETNA‐AF‐Europe 4‐year follow‐up sub‐analysis reaffirms the effectiveness and safety of adherent label‐recommended doses of edoxaban in patients with AF with varying degrees of renal impairment. Low number of patients and events of ¶stroke (n = 2) and †ICH (n = 1) may warrant results to be interpreted with caution.
Raffaele De Caterina   +6 more
wiley   +1 more source

How we treat venous thromboembolism in pregnancy in a resource‐limited setting

open access: yes
HemaSphere, Volume 10, Issue 11, November 2026.
Theresa Nwagha   +5 more
wiley   +1 more source

The Effect of Polycythemia Vera on Pregnancy Complications. The Analysis of an American Population Database With Over 9 Million Deliveries

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1249-1257, November 2026.
ABSTRACT Objectives Polycythemia Vera (PV) is characterized by overproduction of erythrocytes, leading to a hypercoagulable state. Evidence regarding associations between PV and pregnancy outcomes is limited. The aim of our study was to provide robust evidence regarding the prevalence of pregnancy complications in women with PV.
Noah Margolese   +5 more
wiley   +1 more source

Hypothetico‐Deductive Reasoning in Direct Oral Anticoagulant Trial Meta‐Analyses: A Meta‐Epidemiological Study

open access: yesFundamental &Clinical Pharmacology, Volume 40, Issue 6, November 2026.
ABSTRACT Background Direct oral anticoagulants (DOAC) have become standard therapy for thrombosis prevention since 2008. Meta‐analyses (MAs) of randomized controlled trials (RCT) are considered high‐level evidence supporting clinical guidelines. However, methodological biases may yield false‐positive findings, particularly through inadequate hypothesis
Quentin Remy   +4 more
wiley   +1 more source

Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting. [PDF]

open access: yesJ Cardiovasc Dev Dis
Pompei G   +7 more
europepmc   +1 more source

Refining Residual Ischemic Stroke Risk in Anticoagulated Atrial Fibrillation Using Index Outpatient LA Diameter: The CHA2DS2‐VALa Score

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 11, Page 2529-2540, November 2026.
In anticoagulated atrial fibrillation, residual ischemic stroke risk persists despite guideline‐directed therapy. In this single‐center cohort, an enlarged index outpatient left atrial diameter independently predicted stroke and improved risk stratification when added to CHA2DS2‐VA (CHA2DS2‐VALa), supporting a simple, clinically implementable ...
Sefa Erdi Ömür   +7 more
wiley   +1 more source

Time‐Dependent Diagnostic Yield and Therapeutic Impact of Implantable Loop Recorders, Brugada Syndrome as the Exception

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 11, Page 2662-2674, November 2026.
Diagnostic yield and therapeutic impact varied substantially according to the indication for implantation. Actionable diagnoses were concentrated in the early follow‐up period for syncope and palpitations, whereas late atrial fibrillation detection after cryptogenic stroke could still modify antithrombotic management. In contrast, patients with Brugada
Luigi Cocchiara   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy